Protein SORLA May Offer New Route Against Alzheimer’s, Mouse Study Finds
Researchers say boosting a little-known brain protein reduced several tau-related harms in mice, though human studies have not yet been carried out.

Key points
- Scientists at Sanford Burnham Prebys studied the protein SORLA in mice.
- Extra SORLA reduced brain shrinkage and abnormal tau accumulation.
- Mice without SORLA showed more severe tau-related damage.
- The findings were published in Science Advances, according to ScienceDaily.
- Researchers say more work is needed to test the effects in humans.
A little-known protein called SORLA may help protect the brain against damage linked to Alzheimer’s disease, according to a study reported by ScienceDaily. The research was published in the journal Science Advances by scientists at Sanford Burnham Prebys. The team found that boosting the protein in mice reduced several harmful changes, including brain shrinkage and the buildup of abnormal tau proteins.
Tau proteins normally help support the internal structure of nerve cells. In Alzheimer’s and related conditions, they can become abnormal and clump together into tangles. These tangles disrupt nerve cell function and are linked to memory and thinking decline, as well as cell death. Diseases marked by this type of tau buildup are known as tauopathies.
How SORLA Affected Tau in Mice
SORLA, short for sorting-related receptor with A-type repeats, has already drawn attention for its possible role in limiting amyloid-beta, another protein connected to Alzheimer’s. Earlier work suggested SORLA can reduce the build-up of amyloid-beta. The new study asked whether it could also influence tau.
To test this, the researchers bred mice that produce extra human SORLA with mice that develop tau tangles, brain shrinkage and thinking problems. Higher SORLA levels reduced a chemical change known as hyperphosphorylation, in which too many phosphate groups attach to tau. The protein also limited misfolded tau from acting as seeds that cause other tau to clump.
SORLA also appeared to help preserve synapses, the connections that let neurons communicate. It protected synaptic plasticity, the brain’s ability to adjust those connections, which is important for learning and memory. Huijie Huang, a staff scientist in the Huang lab and lead author, said the team saw less brain atrophy and less tau accumulation.
What Happened Without SORLA
The researchers also studied mice that lacked the gene Sorl1, which is needed to make SORLA. In these animals, the harmful effects were worse rather than better. Tim Huang, the senior and corresponding author, said the lack of SORLA made the damage seen in tauopathies more severe.
The team also examined brain cells and surrounding tissue to understand these differences. They found that higher SORLA reduced abnormal gene activity in glial cells, which support and protect neurons. When SORLA was absent, a member of the plexin-B receptor family was more active. Existing drugs can target this receptor family, so researchers may test whether they could help in tau-related dementia.
Limits of the Findings and Next Steps
The results come from mice, so it is not yet clear how these mechanisms work in people. The team plans to study how different brain cell types respond to changes in SORLA levels. One approach would transplant human neurons or glial cells into mouse brains.
Tim Huang said human cells in a diseased brain setting would give more useful information about the disease. The researchers hope a better understanding of SORLA could lead to new treatments, either by boosting the protein or by repurposing existing drugs. Funding for the research came from three agencies: the National Institutes of Health, the National Cancer Institute and the National Institute on Aging.
Frequently asked questions
What is SORLA?
SORLA is a protein, also called sorting-related receptor with A-type repeats. Earlier studies suggested it can help limit amyloid-beta, a protein linked to Alzheimeru0026#039;s disease.
Has this treatment been tested in people?
No. The protective effects were shown in mice, and more research is needed to understand how the mechanisms work in humans.
Who carried out the study?
Scientists at Sanford Burnham Prebys carried out the study, which was published in Science Advances and reported by ScienceDaily.
Sources
This article was written with the help of AI from reports by the outlets listed above. See our Editorial Policy. Spotted a mistake? Tell us.



